EPCAM: A Protein with Potential as A Drug Target and Biomarker

Target Name: EPCAM

NCBI ID: G4072

EPCAM: A Protein with Potential as A Drug Target and Biomarker

EPCAM (endoplasmic reticulum-associated protein kinase-3) is a protein that is expressed in various cell types, including neurons, glial cells, and blood cells. It is a key regulator of the endoplasmic reticulum (ER), which is the protein synthesis and modify the center of the cell. EPCAM plays a crucial role in ensuring the proper delivery and processing of proteins to the ER, and is involved in a wide range of cellular processes, including protein folding, localization, and degradation.

Recent studies have identified EPCAM as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. EPCAM has been shown to be involved in the pathogenesis of several diseases, and its dysregulation has been implicated in a number of diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

One of the key reasons for the interest in EPCAM as a drug target is its involvement in the regulation of protein function. EPCAM is known to play a role in the regulation of protein stability and localization to the ER, and studies have shown that it can alter the stability and localization of various proteins, including transcription factors and cytoskeletal proteins. This suggests that EPCAM may be a useful target for drugs that are designed to modulate protein function and activity.

In addition to its role in protein regulation, EPCAM has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of the nervous system. For example, studies have shown that EPCAM is involved in the regulation of neurogenesis, the process by which new neurons are generated in the brain, and that it plays a role in the maintenance of the neuronal network. EPCAM has also been shown to be involved in the regulation of synaptic plasticity, the ability of the nervous system to change and adapt in response to experience, and in the regulation of pain perception.

Given its involvement in a wide range of cellular processes, including protein regulation, neurogenesis, and synaptic plasticity, EPCAM has potential as a drug target for a wide range of diseases. Studies have shown that EPCAM is a good candidate for small molecules that can modulate its activity, including those that target its activity at the protein level, such as inhibitors of the protein kinase A (PKA), which is a well-known regulator of protein function, and those that target its activity at the gene level, such as small molecules that can interfere with its translation into RNA.

In addition to its potential as a drug target, EPCAM also has potential as a biomarker for a wide range of diseases. Its involvement in the regulation of protein function and its ability to be altered by small molecules make it an attractive candidate for diagnostic tests. For example, studies have shown that EPCAM is downregulated in the brains of individuals with Alzheimer's disease, and that this downregulation is associated with an increased risk of the development of the disease. Similarly, EPCAM has been shown to be involved in the regulation of the expression of genes that are important for the development and maintenance of cancer, and that its expression is often altered in cancer cells.

Overall, EPCAM is a protein that has great potential as a drug target and biomarker for a wide range of diseases. Its involvement in the regulation of protein function and its ability to be altered by small molecules make it an attractive target for the development of new therapies. Further research is needed to fully understand the role of EPCAM in cellular processes and its potential as a drug and biomarker.

Protein Name: Epithelial Cell Adhesion Molecule

Functions: May act as a physical homophilic interaction molecule between intestinal epithelial cells (IECs) and intraepithelial lymphocytes (IELs) at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection. Plays a role in embryonic stem cells proliferation and differentiation. Up-regulates the expression of FABP5, MYC and cyclins A and E

More Common Targets